ePharma Summit Top 5 3

I had the pleasure of attending the ePharma Summit 2013, a premier pharmaceutical marketing event, in New York City March 4-6.  I had high hopes that this conference would be valuable to Lilly COI, but I was a little uncertain.

My uncertainty centered around whether pharma marketing methods, tools, topics, organizations and people would translate to Lilly COI’s objectives of bringing patients to the center of clinical trials and development. How would a pharma marketing conference apply to our R&D work?

Some sessions left me wanting more, as several of the “digital is important” and “you better get mobile” sessions didn’t go deep enough for my tastes.

Still, there were patient-focused sessions that inspire, and sessions that struck chords that continue to resonate. And, I was able to meet plenty of interesting people.

Below are my “Top 5” experiences from the ePharma Summit, in no particular order.

1) Social Media for Pharma: A Match Made in Heaven or Hell?  

For me, the best sessions are those where patients speak. This particular panel was made up of seasoned, digital health activists, ready to share their perspective on how pharma can better engage with them in the digital space. Patients are ready and willing. The ball is in pharma’s court.

A question posed to the panel about what pharma should do resulted in simple, insightful response:

Panelists included:

2) Meeting John Mack, @PharmaGuy

John Mack is the editor and publisher of the Pharma Marketing News and also produces regular thought-provoking content on his Pharma Marketing Blog. John is a marketing guy, but a quick read of his blog shows he has broader insight into the pharma industry, including R&D.

John interviewed us for his post OMG, LCOI! Open Source Pharma: Creative Commons Coming To Pharma and invited us to join him on his Pharma Marketing Talk Interviews with Innovators radio show TransCelerating and Crowdsourcing Pharma R&D.

It was a great pleasure to meet John in person, as his unique voice serves to stimulate lively debate, challenge the industry to do better, and helps show where pharma makes a difference in lives.

3) WEGO Health

We’ve come to know a bit about WEGO Health by proxy, as a number of health activists we have connected with are members. But, we’ve had little direct contact with WEGO Health itself.  WEGO Health is a community of health activists, for health activists. They provide a number of services to meet the needs of those activists, and on their about page they discuss how they are funded:

WEGO Health funds its support for our network through transparent, community-vetted advertising and sponsorships from health companies: research, content development, education, events, conferences, distribution programs, ad networks, and more.

WEGO CEO Jack Barrette and I had some very interesting conversations about the potential for Lilly COI to engage with WEGO Health activists. I look forward to future conversations, as the notion of a community of health activists participating with Lilly COI to drive changes in drug development seem aligned with both of our  visions.

4) Patient Centricity… A Cultural Transformation…Not Just Some Tactics!

Stephanie Schibell, Sanofi-Aventis, led us through her experience and described a cultural progression towards pharma being truly patient-centric.

Schibell’s perspective is that, ultimately, full C-suite integration drives the culture, with score cards, HR decisions, corporate mission/vision and objectives aligned to patient-centricity. It stuck with me when she shared that, at Sanofi, failure is rewarded –  IF the effort was properly focused on the patient.

5) Next Generation Content & Its Promise for Improved Health Outcomes 

Craig A. DeLarge of Merck is a highly credentialed marketeer. But his credentials are not what make him stand out. It is his easy and engaging style that makes you want to listen. Combine that with a compelling presentation about what the future holds, and his session is one that sticks with me.

His message, on the surface, is simple. Good content is about telling stories and playing games. It’s a lot harder than it sounds, but, ultimately it’s what people will respond to.  Expand the slideshare to full screen to see the infographic Craig made to support his talk.

You can watch Craig’s ePharma presentation here.

In conclusion, this marketing summit wasn’t an exact fit to Lilly COI’s mission, but I was able to gather some valuable perspective and make some great connections that will serve us well in the near future.

3 comments

    • Thanks Casey. Not sure if #ePharma will be the place where Lilly COI has the sort of session that you suggest, but we will be having “patient help” sessions along the way as we continue on our path. We’ll be in touch to let you know the whens and wheres.

  1. Pingback: Why Pharma conferences need to be about what patients really need | Tim Batchelder.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s